Loading...
Rein Therapeutics Inc.
RNTX•NASDAQ
Healthcare
Medical - Pharmaceuticals
$1.46
$0.04(2.82%)
Rein Therapeutics Inc. (RNTX) Financial Performance & Income Statement Overview
Review Rein Therapeutics Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-399949.15%
↓ 399949.15%
Net Income Growth
-399613.96%
↓ 399613.96%
Operating Cash Flow Growth
-12.54%
↓ 12.54%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-112.37%
↓ 112.37%
ROIC
-93.75%
↓ 93.75%
Rein Therapeutics Inc. (RNTX) Income Statement & Financial Overview
Review Rein Therapeutics Inc.'s (RNTX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $3.32M | $3722.00 | $3741.00 | $3463.00 |
| SG&A Expenses | $2.48M | $2349.00 | $5298.00 | $3742.00 |
| Operating Expenses | $42.80M | $6071.00 | $9039.00 | $7205.00 |
| Total Costs & Expenses | $42.80M | $6071.00 | $9039.00 | $7205.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $5.79M | $0.00 | $4.00 | $59.00 |
| EBITDA | -$5797.00 | -$6071.00 | -$9035.00 | -$7146.00 |
| EBITDA Ratio | ||||
| Operating Income | -$42.80M | -$6071.00 | -$9039.00 | -$7205.00 |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $272000.00 | $224.00 | $97.00 | $92.00 |
| Income Before Tax | -$42.41M | -$5847.00 | -$8942.00 | -$7113.00 |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $1544.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$40.98M | -$5847.00 | -$8942.00 | -$7113.00 |
| Net Income Ratio | ||||
| EPS | -$1.89 | -$0.27 | -$0.45 | -$0.86 |
| Diluted EPS | -$1.89 | -$0.27 | -$0.45 | -$0.86 |
| Weighted Avg Shares Outstanding | $21693.00 | $21663.00 | $19911.00 | $8301.00 |
| Weighted Avg Shares Outstanding (Diluted) | $21693.00 | $21663.00 | $19911.00 | $8302.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan